<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo>-elicited <z:mp ids='MP_0001845'>inflammatory responses</z:mp> are driven by <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> produced both by central (e.g., neurons and microglia) and infiltrating peripheral immune cells (e.g., macrophage/monocyte), and contribute to the evolution of tissue injury </plain></SENT>
<SENT sid="1" pm="."><plain>A ubiquitous molecule, <z:chebi fb="0" ids="15746">spermine</z:chebi>, is released from injured cells, and counter-regulates release of various proinflammatory cytokines </plain></SENT>
<SENT sid="2" pm="."><plain>However, the <z:chebi fb="0" ids="15746">spermine</z:chebi>-mediated anti-inflammatory activities are dependent on the availability of fetuin-A, a liver-derived negative <z:hpo ids='HP_0011009'>acute</z:hpo>-phase protein </plain></SENT>
<SENT sid="3" pm="."><plain>Using an animal model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (i.e., permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, MCAo), we found that levels of fetuin-A in the ischemic brain tissue were elevated in a time-dependent manner, starting between 2 and 6 h, peaking around 24 to 48 h, and returning to baseline 72 h after MCAo </plain></SENT>
<SENT sid="4" pm="."><plain>When administered peripherally, exogenous fetuin-A gained entry across the <z:chebi fb="2" ids="33602">BBB</z:chebi> into the ischemic brain tissue, and dose dependently reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume at 24 h after MCAo </plain></SENT>
<SENT sid="5" pm="."><plain>Meanwhile, fetuin-A effectively attenuated (i) <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced HMGB1 <z:mpath ids='MPATH_63'>depletion</z:mpath> from the ischemic core; (ii) activation of centrally (e.g., microglia) and peripherally derived immune cells (e.g., macrophage/monocytes); and (iii) TNF production in ischemic brain tissue </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, these experimental data suggest that fetuin-A protects against early cerebral ischemic injury partly by attenuating the brain <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>